|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Total operating loss | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of derivatives | |||||
| Total other expense | |||||
| Net loss | |||||
| Preferred stock dividends | |||||
| Warrant modification | |||||
| Net loss applicable to common stockholders | |||||
| Net loss per common share - basic (in Dollars per share) | |||||
| Net loss per common share - diluted (in Dollars per share) | |||||
| Weighted average common and potential common shares outstanding - basic (in Shares) | |||||
| Weighted average common and potential common shares outstanding - diluted (in Shares) |
Loading...